Entries by Trethera

Trethera Corporation announces appointment of Timothy “Tim” Donahue, M.D. to the Board of Directors 

Los Angeles, January 31, 2019 /PRNewswire/ — Trethera Corporation (Trethera), a biopharmaceutical company committed to developing novel drugs targeting cellular nucleotide metabolism for the treatment of cancer, announced the nomination and acceptance of Timothy Donahue to Trethera’s Board of Directors by unanimous vote of the Board.  “I am delighted to have Dr. Donahue join the […]